SCHEMBL24253452

SCHEMBL24253452

CC(C)c1cc2cnccc2cc1O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RPS6KA3 P51812 1/20 0.43
DAO P14920 2/20 0.40
LMNA P02545 2/20 0.40
TRPA1 O75762 1/20 0.40
CHRM1 P11229 1/20 0.40
SLC6A2 P23975 1/20 0.40
ADRA1A P35348 1/20 0.40
HTR2B P41595 1/20 0.40
ALOX5 P09917 1/20 0.40
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2B6 P20813 1/20 0.39
CYP2C19 P33261 1/20 0.39
HSP90AA1 P07900 7/20 0.39
HSP90AB1 P08238 7/20 0.39
PRKCZ Q05513 1/20 0.39
MELK Q14680 1/20 0.38
KDM4E B2RXH2 1/20 0.38
MAPKAPK2 P49137 1/20 0.38
HASPIN Q8TF76 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24253357 1.00 RPS6KA3 (0.43) RPS6KA3DAOLMNATRPA1CHRM1
SCHEMBL12778210 0.87 PRKCZ (0.44) RPS6KA3ALOX5PRKCZMELKHASPIN
SCHEMBL24925368 0.83 RORC (0.44) DAOCYP3A4CYP2C9CYP2B6CYP2C19
SCHEMBL24924719 0.81 CYP3A4 (0.34) RPS6KA3CYP3A4CYP2C9CYP2B6CYP2C19
SCHEMBL1651489 0.80 DAO (0.50) DAOCYP3A4PRKCZMELKKDM4E
SCHEMBL19068654 0.80 PRKCZ (0.40) RPS6KA3PRKCZMELKHASPINCSNK1D
SCHEMBL13193051 0.80 PRKCZ (0.40) RPS6KA3PRKCZMELKHASPINCSNK1D
SCHEMBL24868090 0.80 PDGFRB (0.39) RPS6KA3CYP3A4CYP2C9CYP2B6CYP2C19
SCHEMBL24253514 0.79 LMNA (0.44) LMNATRPA1CHRM1SLC6A2ADRA1A
SCHEMBL20708825 0.79 RPS6KA3 (0.46) RPS6KA3PRKCZMELKHASPINCSNK1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230227474-A1 COMPOSITIONS AND METHODS FOR CORRECTION OF ABERRANT SPLICING SKYHAWK THERAPEUTICS, INC. (US) 2023-07-20 US disclosed
US-20230227474-A1 COMPOSITIONS AND METHODS FOR CORRECTION OF ABERRANT SPLICING SKYHAWK THERAPEUTICS, INC. (US) 2023-07-20 US disclosed
US-20230069804-A1 METHODS AND COMPOSITIONS FOR MODULATING SPLICING SKYHAWK THERAPEUTICS, INC. 2023-03-02 US disclosed
US-20230054781-A1 METHODS AND COMPOSITIONS FOR MODULATING SPLICING SKYHAWK THERAPEUTICS, INC. 2023-02-23 US disclosed
US-20230027684-A1 METHODS AND COMPOSITIONS FOR MODULATING SPLICING SKYHAWK THERAPEUTICS, INC. 2023-01-26 US disclosed
US-20230008867-A1 METHODS AND COMPOSITIONS FOR MODULATING SPLICING SKYHAWK THERAPEUTICS, INC. 2023-01-12 US disclosed
US-20230009712-A1 METHODS AND COMPOSITIONS FOR MODULATING SPLICING SKYHAWK THERAPEUTICS, INC. 2023-01-12 US disclosed
US-20220048890-A1 METHODS AND COMPOSITIONS FOR MODULATING SPLICING SKYHAWK THERAPEUTICS, INC. 2022-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220048890-A1 METHODS AND COMPOSITIONS FOR MODULATING SPLICING RBM17, SF3B1, SF3B5 RPS6KA3 590/4885DAO 4543/4885LMNA 246/4885
US-20230008867-A1 METHODS AND COMPOSITIONS FOR MODULATING SPLICING RBM17, SF3B1, SNRPA1 RPS6KA3 730/4885DAO 4354/4885LMNA 218/4885
US-20230027684-A1 METHODS AND COMPOSITIONS FOR MODULATING SPLICING RBM17, SF3B1, SF3B5 RPS6KA3 590/4885DAO 4543/4885LMNA 246/4885
US-20230009712-A1 METHODS AND COMPOSITIONS FOR MODULATING SPLICING RBM17, SF3B1, SF3B5 RPS6KA3 590/4885DAO 4543/4885LMNA 246/4885
US-20230227474-A1 COMPOSITIONS AND METHODS FOR CORRECTION OF ABERRANT SPLICING RBM17, SF3B1, SF3B5 RPS6KA3 599/4885DAO 4163/4885LMNA 301/4885
US-20230069804-A1 METHODS AND COMPOSITIONS FOR MODULATING SPLICING RBM17, SF3B1, SF3B5 RPS6KA3 590/4885DAO 4543/4885LMNA 246/4885
US-20230054781-A1 METHODS AND COMPOSITIONS FOR MODULATING SPLICING RBM17, SF3B1, SF3B5 RPS6KA3 590/4885DAO 4543/4885LMNA 246/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.